SNT 25.7% 4.4¢ syntara limited

I never thought I would PXS at this SP level. Long term it looks...

  1. 1,655 Posts.
    lightbulb Created with Sketch. 33
    I never thought I would PXS at this SP level. Long term it looks a great buy but short term SP may go lower leading up to March 18 FDA likely offical rejection. Anyone think this is close to the SP bottom? If FDA gave unlikely approval for +18 usage the SP would fly.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.